Home/Filings/4/0001102624-15-000366
4//SEC Filing

Boston Therapeutics, Inc. 4

Accession 0001102624-15-000366

CIK 0001473579operating

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 2:41 PM ET

Size

4.5 KB

Accession

0001102624-15-000366

Insider Transaction Report

Form 4
Period: 2015-03-10
SQUEGLIA ANTHONY DON
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2015-03-10$0.22/sh+10,000$2,200128,350 total

Issuer

Boston Therapeutics, Inc.

CIK 0001473579

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001473579

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 2:41 PM ET
Size
4.5 KB